Urgent: Transition Your Clinical Trials to CTR Now!

? Attention Sponsors and CROs! A critical deadline is looming for all ongoing clinical trials authorized under the Clinical Trials Directive (CTD) after January 30, 2025. They must transition to the Clinical Trials Regulation (CTR) swiftly.

Sponsors, the clock is ticking. It's your responsibility for a timely transition. An expedited administrative procedure is available, but only until October 16, 2024. For submissions beyond this date, a prompt approval cannot be guaranteed.

?Preparation Time Matters! Waiting until the last moment is not an option. Considering the necessary time for preparation, act now to ensure a smooth transition. Many trials are still awaiting this crucial shift.

??Why trust me? With over two decades entrenched in Regulatory Affairs and Study Start-Up, I haven't just embraced change; I've been impressed and delighted by it, especially in the realm of the Clinical Trial Information System (CTIS).

?? Fueling Passion for CTIS! From its inception, CTIS has been more than a system; it's been a beacon of progress. As a fervent Sponsor Master Trainer, my delight in CTIS is not just professional; it's personal. I've witnessed its transformative power in streamlining submissions and bringing a new era of efficiency to clinical trials.

Ready to Ignite the Transition? ?? Contact Me! If you seek guidance in navigating your clinical trials into CTR compliance, I'm here. Let's work together to ensure your trials not only meet but exceed regulatory milestones.

Act urgently and ensure compliance with the evolving regulatory landscape. The clock is ticking!

#RegulatoryRocks #CTISrocks #TransitionalTrials #CTIS #CTR #ClinicalTrials #SSU #regulatory #regaffairs